CXCR4 and colorectal carcinoma: The c-MYC and CXCR4 panel was able to identify polyp/CRC patients with AUC of 0.88 (p < 0.001), with sensitivity and specificity of 84.4% and 92.3%, respectively (Figure 7(b)).